Ledger.Open graph →
SEC Form D · filed March 1, 2024

Denali Therapeutics Inc

Offering
$499.7M
Sold
$499.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Carole O. Ho · South San Francisco, CAExecMarc P. Tessier-Lavigne · South San Francisco, CADirectorJay T. Flatley · South San Francisco, CADirectorDavid P. Schenkein · South San Francisco, CADirectorVicki L. Sato · South San Francisco, CADirectorNancy A. Thornberry · South San Francisco, CADirectorPeter S. Klein · BELLEVUE, WADirectorErik T. Harris · South San Francisco, CADirectorSteve E. Krognes · South San Francisco, CADirectorJennifer O. Cook · South San Francisco, CADirectorRyan Watts · Dallas, TXExec · DirectorAlexander O. Schuth · South San Francisco, CAExecCarole O. Ho · South San Francisco, CAExecVicki L. Sato · South San Francisco, CADirectorNancy A. Thornberry · South San Francisco, CADirectorPeter S. Klein · BELLEVUE, WADirectorMarc P. Tessier-Lavigne · South San Francisco, CADirectorJay T. Flatley · South San Francisco, CADirectorDavid P. Schenkein · South San Francisco, CADirectorErik T. Harris · South San Francisco, CADirectorSteve E. Krognes · South San Francisco, CADirectorJennifer O. Cook · South San Francisco, CADirectorRyan Watts · Dallas, TXExec · DirectorAlexander O. Schuth · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗